Lateral Arm Free Flap for Reconstruction of the Oral Cavity and Head and Neck Soft Tissue Defects.

Sponsor
hassan harby mohamed (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05296811
Collaborator
(none)
15
1
24
0.6

Study Details

Study Description

Brief Summary

The excision of oral cancers causes extensive impairment of the oral cavity soft tissue. Complete excision of the tumors is vital, and the reconstruction of the resected area influences not only the postoperative recovery period of patients but also physiological functions such as swallowing, phonation function ,daily activities and psychosocial impact.

Oral and maxillofacial surgeons are faced with the task of reconstructing the affected area to reduce these problems as much as possible.

In 1982, Song introduced the lateral arm flap (LAF). Since this time, its used in surgical repairs of oral defects, But the specific subject of publications generally restricted to a small number of cases.

LAF is a thin and pliable flap with consistent anatomy and a high success rate. It is also claimed that there is no risk of vascular compromise to the arm

Condition or Disease Intervention/Treatment Phase
  • Procedure: Lateral Arm Free Flap
N/A

Detailed Description

reconstruction of oral , head and neck defects with Lateral Arm Free Flap

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Lateral Arm Free Flap for Reconstruction of the Oral Cavity and Head and Neck Soft Tissue Defects.
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Early detection of recurrence [3 month]

    reconstruction of defects in head and neck post surgical excision by lateral arm free flap and early detection of recurrence by CT neck.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. All patients post glossectomy.

  2. Patients post maxillectomy with malignant maxillary swelling with no distant metastases.

  3. All patients which defect after surgery for head and neck neoplasia.

Exclusion Criteria:
    1. Small defect post excision can be closed directly 2. medically unfit patients

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assiut University Assiut Egypt 71511

Sponsors and Collaborators

  • hassan harby mohamed

Investigators

  • Principal Investigator: hassan harby, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
hassan harby mohamed, principal investigator, Assiut University
ClinicalTrials.gov Identifier:
NCT05296811
Other Study ID Numbers:
  • Lateral Arm Free Flap
First Posted:
Mar 25, 2022
Last Update Posted:
Mar 25, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 25, 2022